Author: Sangeun Jeon; Meehyun Ko; Jihye Lee; Inhee Choi; Soo Young Byun; Soonju Park; David Shum; Seungtaek Kim
Title: Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs Document date: 2020_3_20
ID: 5f95gve3_4
Snippet: Drug repositioning could be an effective strategy to respond immediately to emerging infectious diseases since the new drug development usually takes more than 10 years 4 . FDA-approved drugs provide safe alternatives only in the case where at least modest antiviral activity can be achieved. Accordingly, several drugs are being tested in numerous clinical trials 5 including remdesivir, lopinavir, and chloroquine 6 ......
Document: Drug repositioning could be an effective strategy to respond immediately to emerging infectious diseases since the new drug development usually takes more than 10 years 4 . FDA-approved drugs provide safe alternatives only in the case where at least modest antiviral activity can be achieved. Accordingly, several drugs are being tested in numerous clinical trials 5 including remdesivir, lopinavir, and chloroquine 6 .
Search related documents:
Co phrase search for related documents- antiviral activity and drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antiviral activity and Drug repositioning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- antiviral activity and effective strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- antiviral activity and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antiviral activity and modest antiviral activity: 1, 2, 3, 4, 5
- antiviral activity and new drug development: 1, 2, 3, 4, 5, 6
- antiviral activity and safe alternative: 1, 2
- antiviral activity and safe alternative provide: 1
- clinical trial and drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and Drug repositioning: 1, 2, 3, 4, 5, 6, 7, 8
- clinical trial and effective strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and FDA approve: 1
- clinical trial and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and new drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- clinical trial and safe alternative: 1, 2, 3, 4, 5, 6, 7, 8, 9
- drug development and effective strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- drug development and immediately respond: 1
- drug development and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- drug development and new drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date